Treatment with adalimumab in patients with chronic inflammatory rheumatic diseases: a study of treatment trajectories on a patient level in routine care

BACKGROUND: Previous experiences with non-medical switching of adalimumab (ADA) in patients with chronic inflammatory rheumatic diseases (CIRD) come mainly from phase III extension of randomised clinical trials and little from routine care. OBJECTIVES: To analyse treatment trajectories over 2 years...

Descripción completa

Detalles Bibliográficos
Autores principales: Redeker, Imke, Moustakis, Stefan, Tsiami, Styliani, Baraliakos, Xenofon, Andreica, Ioana, Buehring, Bjoern, Braun, Jürgen, Kiltz, Uta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492472/
https://www.ncbi.nlm.nih.gov/pubmed/37694183
http://dx.doi.org/10.1177/1759720X231197087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492472/
https://www.ncbi.nlm.nih.gov/pubmed/37694183
http://dx.doi.org/10.1177/1759720X231197087

Ejemplares similares